SMSPHARMA Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
SMS Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹193.85 |
52 Week High | ₹221.90 |
52 Week Low | ₹85.05 |
Beta | 1.18 |
1 Month Change | -3.49% |
3 Month Change | 6.51% |
1 Year Change | 126.20% |
3 Year Change | 22.11% |
5 Year Change | 238.31% |
Change since IPO | 439.60% |
Recent News & Updates
Recent updates
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?
Oct 08Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?
Sep 17SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 26SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Could Signal Some Risk
Aug 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Business Is Trailing The Market But Its Shares Aren't
Aug 08SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Looks Just Right
Jul 25Shareholder Returns
SMSPHARMA | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -6.3% | -1.8% | -1.9% |
1Y | 126.2% | 51.6% | 41.0% |
Return vs Industry: SMSPHARMA exceeded the Indian Pharmaceuticals industry which returned 51.6% over the past year.
Return vs Market: SMSPHARMA exceeded the Indian Market which returned 41% over the past year.
Price Volatility
SMSPHARMA volatility | |
---|---|
SMSPHARMA Average Weekly Movement | 9.1% |
Pharmaceuticals Industry Average Movement | 5.8% |
Market Average Movement | 6.4% |
10% most volatile stocks in IN Market | 9.5% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: SMSPHARMA's share price has been volatile over the past 3 months.
Volatility Over Time: SMSPHARMA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 1,095 | Ramesh Potluri | www.smspharma.com |
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-fungal, anti-viral, anti-coagulant, and anti-retroviral products. It is also involved in the contract research activities.
SMS Pharmaceuticals Limited Fundamentals Summary
SMSPHARMA fundamental statistics | |
---|---|
Market cap | ₹16.41b |
Earnings (TTM) | ₹498.26m |
Revenue (TTM) | ₹7.14b |
32.9x
P/E Ratio2.3x
P/S RatioIs SMSPHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SMSPHARMA income statement (TTM) | |
---|---|
Revenue | ₹7.14b |
Cost of Revenue | ₹4.98b |
Gross Profit | ₹2.16b |
Other Expenses | ₹1.66b |
Earnings | ₹498.26m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 5.89 |
Gross Margin | 30.27% |
Net Profit Margin | 6.98% |
Debt/Equity Ratio | 52.2% |
How did SMSPHARMA perform over the long term?
See historical performance and comparison